What is ZeOmega?
Founded in 2001 and headquartered in Plano, Texas, ZeOmega provides comprehensive population health management solutions. The company serves a diverse clientele, including commercial health plans, Medicaid managed care organizations, Medicare Advantage plans, and large-scale health systems. By leveraging advanced analytics and care coordination tools, ZeOmega enables these organizations to optimize clinical outcomes and operational efficiencies. Its platform acts as a central nervous system for health data, facilitating the transition from fee-for-service to value-based reimbursement structures, which is essential for modern healthcare providers navigating regulatory and financial pressures.
How much funding has ZeOmega raised?
ZeOmega has raised a total of $23.5M across 2 funding rounds:
Private Equity
$21.5M
Debt
$2M
Private Equity (2013): $21.5M with participation from Bregal Sagemount, BlueCross BlueShield Venture Partners, and Sandbox Industries
Debt (2020): $2M led by PPP
Key Investors in ZeOmega
Bregal Sagemount
Bregal Sagemount is a private equity and venture capital firm specializing in growth capital, middle market, and later-stage financing for mature companies.
BlueCross BlueShield Venture Partners
This firm manages significant capital to invest in emerging companies of strategic relevance to Blue Cross and Blue Shield plans, focusing on healthcare innovation.
Sandbox Industries
A venture capital firm that operates at the intersection of entrepreneurial innovation and large corporate enterprises, with a specific focus on the healthcare sector.
What's next for ZeOmega?
With the recent capital injection, ZeOmega is well-positioned to accelerate its product roadmap and expand its footprint in the enterprise healthcare market. The strategic focus will likely center on enhancing interoperability across disparate health systems and deepening the analytical capabilities of its population health platform. As the industry continues to prioritize data-driven decision-making, ZeOmega's role in bridging the gap between clinical data and actionable insights will be pivotal. Future growth will likely involve scaling its service offerings to meet the evolving needs of Accountable Care Organizations (ACOs) and other risk-bearing entities, ensuring the company remains at the forefront of the digital health transformation.
See full ZeOmega company page
